Literature DB >> 12828398

Development of hand function among children with cerebral palsy: growth curve analysis for ages 16 to 70 months.

Steven E Hanna1, Mary C Law, Peter L Rosenbaum, Gillian A King, Stephen D Walter, Nancy Pollock, Dianne J Russell.   

Abstract

This study documents the development of hand and upper-extremity function in young children who have cerebral palsy (CP) with upper-extremity involvement using longitudinal data. Assessments of hand function and the quality of upper-extremity movement were conducted on 29 males and 22 females (mean age 36.2 months, SD 10.6; age range 16 to 60 months at baseline) and on four other occasions over 10 months. Linear mixed effects modeling was used to estimate average developmental curves and the degree of individual differences in the patterns of development which were conditional on the body-site distribution of CP and severity of impairments. Results indicate that hand function in this clinical population develops differently from overall upper-extremity skills with declines in function in upper-extremity skills being more common and pronounced among older children. However, there is substantial interindividual variation. Distribution of CP and severity of impairments were significant predictors of development. Results are discussed in terms of their clinical implications.

Entities:  

Mesh:

Year:  2003        PMID: 12828398

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  9 in total

1.  Classification of speech and language profiles in 4-year-old children with cerebral palsy: a prospective preliminary study.

Authors:  Katherine C Hustad; Kristin Gorton; Jimin Lee
Journal:  J Speech Lang Hear Res       Date:  2010-07-19       Impact factor: 2.297

2.  Child health research in Canada: Alive and well?

Authors:  Peter Rosenbaum
Journal:  Paediatr Child Health       Date:  2004-07       Impact factor: 2.253

3.  Assessment of social function in four-year-old children with cerebral palsy.

Authors:  Emily McFadd; Katherine C Hustad
Journal:  Dev Neurorehabil       Date:  2013       Impact factor: 2.308

Review 4.  Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).

Authors:  Brian J Hoare; Margaret A Wallen; Christine Imms; Elmer Villanueva; Hyam Barry Rawicki; Leeanne Carey
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

5.  Manual Ability Classification System (MACS): reliability between therapists and parents in Brazil.

Authors:  Daniela B R Silva; Carolina A R Funayama; Luzia I Pfeifer
Journal:  Braz J Phys Ther       Date:  2015-02-03       Impact factor: 3.377

6.  Relationship between gross motor function and the function, activity and participation components of the International Classification of Functioning in children with spastic cerebral palsy.

Authors:  Byoung-Hee Lee
Journal:  J Phys Ther Sci       Date:  2017-10-21

7.  The Effectiveness of a Computer Game-Based Rehabilitation Platform for Children With Cerebral Palsy: Protocol for a Randomized Clinical Trial.

Authors:  Anuprita Kanitkar; Tony Szturm; Sanjay Parmar; Dorcas Bc Gandhi; Gina Ruth Rempel; Gayle Restall; Monika Sharma; Amitesh Narayan; Jeyaraj Pandian; Nilashri Naik; Ravi R Savadatti; Mahesh Appasaheb Kamate
Journal:  JMIR Res Protoc       Date:  2017-05-18

8.  Time Course of Upper Limb Function in Children with Unilateral Cerebral Palsy: A Five-Year Follow-Up Study.

Authors:  Katrijn Klingels; Sarah Meyer; Lisa Mailleux; Cristina Simon-Martinez; Jasmine Hoskens; Elegast Monbaliu; Geert Verheyden; Geert Verbeke; Guy Molenaers; Els Ortibus; Hilde Feys
Journal:  Neural Plast       Date:  2018-11-14       Impact factor: 3.599

9.  Early childhood constraint therapy for sensory/motor impairment in cerebral palsy: a randomised clinical trial protocol.

Authors:  Olena Chorna; Jill Heathcock; Alexandra Key; Garey Noritz; Helen Carey; Ellyn Hamm; Mary Ann Nelin; Micah Murray; Amy Needham; James C Slaughter; Nathalie L Maitre
Journal:  BMJ Open       Date:  2015-12-07       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.